Introduction
============

Hypertension is a common complex disease affected by the mutual influence of multiple genetic and environmental factors.[@b1-cia-11-017],[@b2-cia-11-017] It is a major risk factor for many disorders, such as renal failure, stroke, and cardiovascular disease,[@b3-cia-11-017],[@b4-cia-11-017] and its heritability ranges from 30% to 50%.[@b5-cia-11-017],[@b6-cia-11-017] However, the definite genetic background of hypertension is difficult to determine and remains inconclusive. Molecular genetics research has been attempting to ascertain the inherited susceptible genes of hypertension. Numerous efforts have been concentrated on the abnormal renal handling of sodium chloride metabolism in the pathogenesis of hypertension, considering that the kidney plays an important role in the long-term control of blood pressure and is the major organ involved in the regulation of sodium homeostasis.[@b7-cia-11-017],[@b8-cia-11-017] Therefore, *GRK4* and *DRD1* genes have been assessed as the potential candidates.

*GRK*s are a seven-member family of serine/threonine protein kinases distinguished by their ability to specifically recognize, phosphorylate -- and desensitize agonist-activated *GPCR*s.[@b9-cia-11-017] The sodium retention in hypertension is on account of increased sodium transport and/or deficiency to respond appropriately to signs that decrease sodium transport.[@b10-cia-11-017] The process of sodium transport is regulated by natriuretic and anti-natriuretic hormones, which exert their effects by *GPCR*s. Thus, *GRK*-mediated receptor phosphorylation is one of the well-distinguished mechanisms for *GPCR* desensitization. Interestingly, *GRK4*, different from the other *GRK*s in tissue distribution, is abundantly expressed in the kidney and seems to play a vital role in the regulation of sodium metabolism.[@b11-cia-11-017] *GRK4* gene is located in chromosome 4 (4p16.3) and four splice variants (*GRK4*α, β, γ, δ) have been identified in humans.[@b12-cia-11-017] An increasing number of studies show that *GRK4* gene is associated with hypertension and blood pressure in different ethnic populations.[@b13-cia-11-017]--[@b16-cia-11-017] Among them, rs2960306 (R65L), rs1024323 (A142V), and rs1801058 (A486V) polymorphisms have attracted the most attention.

*GRK4* mainly exerts its function by *DRD1* and its impaired coupling of *DRD1* and its G-protein effector enzyme complex has been linked to the dopamine-mediated sodium dysregulation.[@b10-cia-11-017] Likewise, *DRD1*-deficient mice develop hypertension.[@b17-cia-11-017] Therefore, *DRD1* seems to be a risk factor in the development of hypertension, considering that dopaminergic and cholinergic neurotransmitters mainly regulate blood pressure by binding to their respective receptors.[@b18-cia-11-017] Many efforts have been made to screen the latent pathogenic variations of *DRD1* gene. Among them, rs4532 (A48G), localizing the promoter region, was found to be associated with hypertension in Japanese and Chinese.[@b19-cia-11-017],[@b20-cia-11-017] This single nucleotide polymorphism may affect the expression of *DRD1* by impacting micro RNA-mediated posttranscriptional regulation.[@b21-cia-11-017]

Recently, many molecular epidemiological studies[@b22-cia-11-017]--[@b31-cia-11-017] were performed to investigate the association between the four aforementioned loci and hypertension. Unfortunately, the results were conflicting or inconsistent, most likely due to small sample size, diverse genetic backgrounds, and potential confounding bias. Meta-analysis is a widely used statistical method in medical study, particularly for a subject being extensively investigated while controversial results are being reported.[@b32-cia-11-017] One meta-analysis was performed in 2012 to evaluate the association of three polymorphisms (rs2960306, rs1024323, and rs1801058) of *GRK4* gene with hypertension.[@b33-cia-11-017] The pooled result showed that rs1801058 was associated with hypertension in East Asians and Europeans and there was a significant association between rs2960306 and hypertension among Europeans. However, Liu and Xi's meta-analysis only included five studies and the literature search was updated in September 2011. Additionally, new molecular epidemiological studies have recently been conducted to investigate the role of *GRK4* gene variations in the occurrence of hypertension in different populations and provide new evidences that were not included in the previous meta-analysis. Furthermore, the association of rs4532 polymorphism of *DRD1* gene in the disease has not been clarified in the meta-analysis. Consequently, we carried out a meta-analysis of studies examining these single nucleotide polymorphisms to provide a more comprehensive assessment of the association of *GRK4* and *DRD1* polymorphisms with hypertension.

Materials and methods
=====================

Identification and eligibility of relevant studies
--------------------------------------------------

To identify studies eligible for inclusion in this meta-analysis, five online electronic databases (PubMed, Embase, and Web of Science in English; and China National Knowledge Infrastructure and Wanfang Database in Chinese) were searched (the last search update was August 2015). The following keywords were used in the literature search: G-protein coupled receptor kinase 4, *GRK4*, dopamine receptor 1, *DRD1*, hypertension, and preeclampsia. Reference lists from retrieved articles and potentially relevant review articles were also hand-searched for additional studies. Studies met the following inclusion criteria: 1) case-control design, regardless of sample size, using hospital-based or population-based controls; 2) patients with hypertension; and 3) presented available allele or genotype frequencies. For duplicate publication, the most recent or largest articles were included. Study authors were contacted for additional details (eg, allele or genotype frequencies or sample characteristics) if we needed to retrieve additional data which were not stated in the original report.

Data extraction
---------------

Based on the inclusion criteria, two reviewers (He Zhang and Zhao-qing Sun) independently extracted the information from all qualified literatures. Disagreements were resolved through discussion until the two reviewers reached a consensus. The following data were extracted from each study: first author's last name, publication year, region, and counts of alleles and genotypes between cases and controls. To delineate potential moderating influences on the effects obtained from the case-control studies under consideration, we also included the following variables: 1) ethnicity of the sample population; 2) source of the controls; 3) mean age of the control and case group; 4) sex proportion; and 5) definition of hypertension and controls.

Quality assessment
------------------

Two authors (He Zhang and Shuang-shuang Liu) independently assessed the quality of the included studies according to the Newcastle--Ottawa Scale ([www.ohri.ca/programs/clinical_epidemiology/oxfprd.asp](http://www.ohri.ca/programs/clinical_epidemiology/oxfprd.asp)). This scale consists of three components related to sample selection, comparability, and ascertainment of exposure. A score of 5 or more (maximum of 9) was regarded as "high quality"; studies with scores from 0 to 4 were considered "low quality".[@b34-cia-11-017]

Statistical analysis
--------------------

All statistical tests were two-sided, and *P*\<0.05 was considered statistically significant. The meta-analysis was performed using Stata version 10.0 (Stata Corp LP, College Station, TX, USA). Hardy--Weinberg equilibrium (HWE) in the genotype distribution of controls was calculated again in our meta-analysis. The chi-square goodness of fit was used to test deviation from HWE.

The strength of the association between the target locus and hypertension was estimated by odds ratios (ORs) with 95% confidence intervals (CIs). Pooled effect sizes across studies were performed by a random effects model.[@b35-cia-11-017] Overall pooled ORs were calculated using the allele contrast model, dominant model, and recessive model. Comparisons of OR~1~ (AA vs aa), OR~2~ (Aa vs aa) and OR~3~ (AA vs Aa) were explored with A as the risk allele.[@b32-cia-11-017] The aforementioned pairwise differences were used to determine the most appropriate genetic model. If OR~1~ = OR~3~ ≠1 and OR~2~ =1, then a recessive model was selected. If OR~1~ = OR~2~ ≠1 and OR~3~ =1, then a dominant model was selected. If OR~2~ =1/OR~3~ ≠1 and OR~1~ =1, then a complete overdominant model was selected. If OR~1~ \> OR~2~ \> 1 and OR~1~ \> OR~3~ \> 1 (or OR~1~ \< OR~2~ \< 1 and OR~1~ \< OR~3~ \< 1), then a codominant model was selected.[@b36-cia-11-017]

The degree of heterogeneity was determined by Q-statistic, and *P*-value and *I*^2^ were used to evaluate the heterogeneity among different studies.[@b37-cia-11-017]--[@b39-cia-11-017] Subgroup analysis was performed by ethnicity (East Asian, African, and Caucasian) and source of controls (hospital-based and population-based). Meta-regression was employed to explore the potential sources of heterogeneity including publication date, ethnicity, source of controls, mean age of control and case group, and sex. An estimate of publication bias was assessed by funnel plot and Egger's test.[@b40-cia-11-017] Sensitivity analysis was also performed to weight the potential influences of every single study on the pooled effect size.[@b41-cia-11-017]

Results
=======

After the removal of overlapping articles and those that did not meet the inclusion criteria, a total of 15 articles including 29 studies were finally included in our meta-analysis.[@b19-cia-11-017],[@b20-cia-11-017],[@b22-cia-11-017]--[@b31-cia-11-017],[@b42-cia-11-017]--[@b44-cia-11-017] The main characteristics of the included studies were presented in [Table 1](#t1-cia-11-017){ref-type="table"}. For *GRK4* gene, seven studies with 1,704 cases and 1,705 controls dealt with rs1801058, six studies with 1,598 cases and 1,611 controls dealt with rs2960306, and nine studies with 1,973 cases and 1,946 controls dealt with rs1024323. For *DRD1* gene, seven studies with 2,083 cases and 1,383 controls dealt with rs4532. Of the total 29 studies, Sanada et al' study concerning rs1801058 and rs2960306 presented significant deviation from HWE.[@b19-cia-11-017] In light of Newcastle--Ottawa Scale, eleven articles are high quality and four articles are low quality. Genotype and allele frequencies, HWE, and sample size information are described in [Tables 2](#t2-cia-11-017){ref-type="table"}[](#t3-cia-11-017){ref-type="table"}[](#t4-cia-11-017){ref-type="table"}--[5](#t5-cia-11-017){ref-type="table"}.

Quantitative synthesis and heterogeneity analysis
-------------------------------------------------

### Association of rs1801058 locus (*GRK4* A486V) with hypertension

We analyzed seven studies with 1,704 cases and 1,705 controls dealt with the association between rs1801058 and hypertension. The dominant model was determined according to the principle of genetic model selection ([Table 6](#t6-cia-11-017){ref-type="table"}, [Figure 1](#f1-cia-11-017){ref-type="fig"}).[@b36-cia-11-017],[@b45-cia-11-017] The summary results indicated that there was no association between rs1801058 locus and the occurrence of hypertension. The pooled OR using random effects model was 1.243 (95% CI =0.789--1.958, *P*=0.349). Subgroup analysis for ethnicity indicated that the locus was not associated with hypertension among East Asians, Africans, and Caucasians ([Table 7](#t7-cia-11-017){ref-type="table"}). Moreover, no association between rs1801058 locus and hypertension was observed when subgroup analysis for source of controls was conducted. Significant heterogeneity was observed, thus a meta-regression was conducted subsequently to explore the heterogeneity sources. However, the results of meta-regression indicated that ethnicity (*P*=0.346), source of controls (*P*=0.776), age of the control group (*P*=0.285), age of the case group (*P*=0.200), and sex index (*P*=0.956) had no statistical significance except for publication date (*P*=0.020).

### Association of rs2960306 locus (*GRK4* R65L) with hypertension

We analyzed six studies with 1,598 cases and 1,611 controls dealt with the association between rs2960306 and hypertension. The dominant model was determined according to the principle of genetic model selection ([Table 6](#t6-cia-11-017){ref-type="table"}, [Figure 2](#f2-cia-11-017){ref-type="fig"}). The summary results indicated that there was no association between rs2960306 locus and the occurrence of hypertension. The pooled OR using random effects model was 1.304 (95% CI =0.793--2.145, *P*=0.295). Subgroup analysis for ethnicity indicated that the locus was not associated with hypertension among East Asians, Africans, and Caucasians ([Table 7](#t7-cia-11-017){ref-type="table"}). Moreover, no association between rs2960306 locus and hyper tension was observed when subgroup analysis for source of controls was conducted. Significant heterogeneity was observed, thus a meta-regression was conducted subsequently to explore the heterogeneity sources. However, the results of meta-regression indicated that publication date (*P*=0.063), ethnicity (*P*=0.786), source of controls (*P*=0.963), age of the control group (*P*=0.469), age of the case group (*P*=0.236), and sex index (*P*=0.757) had no statistical significance.

### Association of rs1024323 locus (*GRK4* A142V) with hypertension

We analyzed nine studies with 1,973 cases and 1,946 controls dealt with the association between rs1024323 and hypertension. The dominant model was determined according to the principle of genetic model selection ([Table 6](#t6-cia-11-017){ref-type="table"}, [Figure 3](#f3-cia-11-017){ref-type="fig"}). The summary results indicated that there was no association between rs1024323 locus and the occurrence of hypertension. The pooled OR using random effects model was 1.190 (95% CI =0.785--1.805, *P*=0.413). Subgroup analysis for ethnicity indicated that the locus was associated with hypertension in Caucasians (OR =1.826, 95% CI =1.215--2.745, *P*=0.004) but not in East Asians and Africans ([Table 7](#t7-cia-11-017){ref-type="table"}). Moreover, the association between rs1024323 locus and hypertension was observed when subgroup analysis for source of controls was conducted (hospital-based subgroup: OR =1.546, 95% CI =1.092--2.190, *P*=0.014). Significant heterogeneity was observed, thus a meta-regression was conducted subsequently to explore the heterogeneity sources. However, the results of meta-regression indicated that publication date (*P*=0.913), ethnicity (*P*=0.640), source of controls (*P*=0.234), age of the control group (*P*=0.442), age of the case group (*P*=0.917), and sex index (*P*=0.674) had no statistical significance.

### Association of rs4532 locus with hypertension

We analyzed seven studies with 2,083 cases and 1,383 controls dealt with the association between rs4532 and hypertension. The dominant model was determined according to the principle of genetic model selection ([Table 6](#t6-cia-11-017){ref-type="table"}, [Figure 4](#f4-cia-11-017){ref-type="fig"}). The summary results indicated that there was an association between rs4532 locus and the occurrence of hypertension. The pooled OR using random effects model was 1.353 (95% CI =1.016--1.802, *P*=0.038). Subgroup analysis for ethnicity indicated that the locus was associated with hypertension in East Asians (OR =1.833, 95% CI =1.415--2.376, *P*\<0.001) but not in Caucasians ([Table 7](#t7-cia-11-017){ref-type="table"}). Moreover, no association between rs4532 locus and hypertension was observed when subgroup analysis for source of controls was conducted. Significant heterogeneity was observed, thus a meta-regression was conducted subsequently to explore the heterogeneity sources. However, the results of meta-regression indicated that publication date (*P*=0.185), source of controls (*P*=0.911), age of the case group (*P*=0.240), and sex index (*P*=0.082) had no statistical significance except for ethnicity (*P*\<0.001) and age of the control group (*P*=0.002).

Sensitivity analysis
--------------------

Sensitivity analysis was carried out for each meta-analysis to address the influence of each study. Corresponding pooled ORs showed no significant change when one study was omitted at a time from each meta-analysis, implying that the results were stable and reliable.

Publication bias
----------------

A funnel plot was used to analyze the potential publication bias ([Figure 5](#f5-cia-11-017){ref-type="fig"}). Egger's test was performed to provide the statistical evidence for funnel plot symmetry and the result did not show any evidence of publication bias.

Discussion
==========

The present meta-analysis included 15 articles containing 29 studies that investigated the association between *GRK4* and *DRD1* gene polymorphism and the occurrence of hypertension. Overall, our meta-analytical results provided evidences that rs1024323 (*GRK4* A142V) and rs4532 loci were associated with hypertension in Caucasians and East Asians, respectively. Subgroup analysis stratified by ethnicity and source of controls further explored the distribution disequilibrium of cases and controls. Sensitivity analysis and the examination of publication bias strengthened the validity of the results.

Previous studies reported the association between the polymorphisms of *GRK4* gene and hypertension.[@b13-cia-11-017]--[@b16-cia-11-017] Additionally, one meta-analysis has been done to investigate the association of *GRK4* polymorphisms with hypertension, which suggested that rs1801058 (*GRK4* A486V) and rs2960306 (*GRK4* R65L) loci were associated with hypertension.[@b33-cia-11-017] However, our results observed that rs1024323 and rs4532, rather than rs1801058 and rs2960306, were related to hypertension. To some extent, the current meta-analysis possessed several advantages over the previous study with respect to the following points. First, we included the recent published studies concerned with the association between *GRK4* polymorphism and the occurrence of hypertension, which could provide more credibility for the final results. Second, besides stratified analyses by ethnicity and source of controls, we further performed meta-regression to assess potential sources of heterogeneity and study stability. Finally, for rs4532 locus of *DRD1* gene, it was the first time that its association with the occurrence of hypertension was evaluated. To some degree, our study could provide a more precise assessment of the association between *GRK4* gene and hypertension on account of the aforementioned points.

Obviously, it is reasonable that the participation degree of the hereditary factor is distinct among various ethnic populations.[@b46-cia-11-017] Actually, the frequency distributions of many loci are also not the same in different ethnicities. Thus, it could well be explained that rs1024323 polymorphism was associated with hypertension in Caucasians but not in East Asians and Africans, and the association between rs4532 and hypertension was observed in East Asians but not in Caucasians. Nevertheless, the flowing and mixing of the current population will complicate the future studies and raise the rebalance of blood pressure. The variant of rs1024323 is the allelic variant GCC to GTC, which results in the amino acid substitution of alanine to valine in residue 142. This change is related to a constitutive increase in GRK4 activity in proximal tubular cells.[@b47-cia-11-017] In addition, the experimental cell and animal models implicate abnormalities in dopamine receptor regulation due to receptor desensitization resulting from increased *GRK4* activity, then decreased *DRD* activity and increased *AT1* receptor activity.[@b48-cia-11-017]--[@b50-cia-11-017] For rs4532, located in the 5′ untranslated region of *DRD1* gene, the variant modulates the expression and stability of mRNA and influences *DRD1* gene expression by modifying the interaction between DNA binding domain and the regulatory elements.[@b51-cia-11-017]

Limitations
===========

There are several potential limitations in the present study. First, we did not assess the influence of incongruity among different definitions of hypertension patients and normotensive controls, mainly due to lacking sufficient original data. Second, rs1024323 polymorphism was associated with hypertension in Caucasians. However, there were only two studies in a Caucasian population, so the sample size was not large enough to draw meaningful conclusions, considering that small samples with limited participants are usually accompanied by selection bias.[@b52-cia-11-017]

Conclusion
==========

In summary, our results suggest that rs1024323 of *GRK4* and rs4532 of *DRD1* loci were associated with hypertension in Caucasians and East Asians, respectively. Large sample epidemiological studies, especially in different ethnic populations, need to confirm the findings of our meta-analysis and investigate the latent gene--gene and/or gene--environment interactions between the susceptibility gene and hypertension.
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**Note:** Weights are from random effects analysis.\
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![Forest plot of the association between *DRD1* rs4532 locus and hypertension in dominant model (GA + GG vs AA).\
**Note:** Weights are from random effects analysis.\
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![Funnel plot analysis on the detection of publication bias in the association between *GRK4* and *DRD1* gene polymorphisms and hypertension.\
**Notes:** (**A**) For *GRK4* rs1801058 (*GRK4* A486V); (**B**) for *GRK4* rs2960306 (*GRK4* R65L); (**C**) for *GRK4* rs1024323 (*GRK4* A142V); (**D**) for *DRD1* rs4532.\
**Abbreviation:** OR, odds ratio.](cia-11-017Fig5){#f5-cia-11-017}

###### 

Baseline characteristics of qualified studies in this meta-analysis

  Author                                     Year   Country                      Ethnicity     Controls source    Mean age of control group (years)   Mean age of case group (years)   Sex index   NOS scores
  ------------------------------------------ ------ ---------------------------- ------------- ------------------ ----------------------------------- -------------------------------- ----------- ------------
  Sato et al[@b43-cia-11-017]                2000   Japan                        East Asians   Population-based   49.00                               49.00                            1.69        6
  Bengra et al[@b22-cia-11-017]              2002   Italy                        Caucasians    Hospital-based     --                                  --                               --          3
  Yuan et al[@b42-cia-11-017]                2002   People's Republic of China   East Asians   Hospital-based     56.48                               57.50                            0.74        5
  Beige et al[@b30-cia-11-017]               2004   Canada                       Caucasians    Hospital-based     30.70                               54.60                            1.50        7
  Speirs et al[@b24-cia-11-017]              2004   Australia and UK             Caucasians    Population-based   47.00                               54.00                            1.99        8
  Williams et al[@b23-cia-11-017]            2004   Ghana                        Africans      Hospital-based     --                                  --                               --          5
  Wang et al[@b25-cia-11-017]                2006   People's Republic of China   East Asians   Population-based   53.51                               53.57                            1.01        6
  Xu et al[@b20-cia-11-017]                  2006   People's Republic of China   East Asians   Hospital-based     49.28                               50.19                            0.88        6
  Cao et al[@b28-cia-11-017]                 2007   People's Republic of China   East Asians   Hospital-based     --                                  --                               --          3
  Martinez Cantarin et al[@b26-cia-11-017]   2010   USA                          Africans      Population-based   36.00                               40.00                            0.61        9
  Sun and Zhang[@b27-cia-11-017]             2010   People's Republic of China   East Asians   Hospital-based     30.36                               29.13                            --          6
  Orun et al[@b44-cia-11-017]                2011   Turkey                       Caucasians    Population-based   36.70                               58.12                            2.26        5
  Cipolletta et al[@b31-cia-11-017]          2012   Italy                        Caucasians    Hospital-based     --                                  56.01                            --          4
  Kimura et al[@b29-cia-11-017]              2012   Brazil                       Africans      Population-based   32.00                               55.70                            1.14        4
  Sanada et al[@b19-cia-11-017]              2015   Japan                        East Asians   Population-based   57.50                               56.20                            0.86        8

**Note:** Sex index = (female cases/male cases)/(female controls/male controls).

**Abbreviation:** NOS, Newcastle--Ottawa Scale.

###### 

Distribution of genotype and allele frequencies of the *GRK4* rs1801058 (*GRK4* A486V) locus

  Author                                     Genotype distribution   *P*~HWE~   Allele frequency   Sample size                                                         
  ------------------------------------------ ----------------------- ---------- ------------------ ------------- ----- ---- -------- ------ ------ ------ ------ ----- -----
  Bengra et al[@b22-cia-11-017]              24                      23         13                 28            25    7    0.6966   59.2   40.8   67.5   32.5   60    60
  Williams et al[@b23-cia-11-017]            31                      64         29                 12            25    14   0.8972   50.8   49.2   48.0   52.0   124   51
  Speirs et al[@b24-cia-11-017]              57                      77         26                 117           166   29   0.0058   59.7   40.3   64.1   35.9   160   312
  Wang et al[@b25-cia-11-017]                400                     97         6                  372           109   9    0.7575   89.2   10.8   87.0   13.0   503   490
  Martinez Cantarin et al[@b26-cia-11-017]   49                      90         26                 60            115   31   0.0459   57.0   43.0   57.0   43.0   165   206
  Sanada et al[@b19-cia-11-017]              424                     153        10                 433           45    5    0.0036   85.3   14.7   94.3   5.7    587   483
  Sun and Zhang[@b27-cia-11-017]             31                      63         11                 35            53    15   0.4809   59.5   40.5   59.7   40.3   105   103

**Note:** *P*~HWE~ represents the *P*-value of Hardy--Weinberg equilibrium test in the genotype distribution of controls.

###### 

Distribution of genotype and allele frequencies of the *GRK4* rs2960306 (*GRK4* R65L) locus

  Author                                     Genotype distribution   *P*~HWE~   Allele frequency   Sample size                                                         
  ------------------------------------------ ----------------------- ---------- ------------------ ------------- ----- ---- -------- ------ ------ ------ ------ ----- -----
  Bengra et al[@b22-cia-11-017]              27                      22         11                 28            25    7    0.6966   63.3   36.7   67.5   32.5   60    60
  Williams et al[@b23-cia-11-017]            12                      62         51                 8             23    20   0.7470   34.4   65.6   38.2   61.8   125   51
  Speirs et al[@b24-cia-11-017]              60                      84         24                 76            92    21   0.3818   60.7   39.3   64.6   35.4   160   312
  Wang et al[@b25-cia-11-017]                344                     143        16                 309           156   25   0.3621   82.6   17.4   79.0   21.0   503   490
  Martinez Cantarin et al[@b26-cia-11-017]   53                      82         27                 73            111   30   0.2359   58.0   42.0   60.0   40.0   162   214
  Sanada et al[@b19-cia-11-017]              361                     204        23                 393           79    12   0.0018   78.7   21.3   89.4   10.6   588   484

**Note:** *P*~HWE~ represents the *P*-value of Hardy--Weinberg equilibrium test in the genotype distribution of controls.

###### 

Distribution of genotype and allele frequencies of the *GRK4* rs1024323 (*GRK4* A142V) locus

  Author                                     Genotype distribution   *P*~HWE~   Allele frequency   Sample size                                                          
  ------------------------------------------ ----------------------- ---------- ------------------ ------------- ----- ----- -------- ------ ------ ------ ------ ----- -----
  Bengra et al[@b22-cia-11-017]              15                      29         16                 25            26    9     0.6039   49.2   50.8   63.3   36.7   60    60
  Williams et al[@b23-cia-11-017]            99                      21         4                  42            9     0     0.4895   88.3   11.7   91.2   8.8    124   51
  Speirs et al[@b24-cia-11-017]              31                      84         30                 79            134   35    0.0683   50.3   49.7   58.9   41.1   145   248
  Wang et al[@b25-cia-11-017]                169                     218        116                96            226   168   0.2055   55.3   44.7   42.7   57.3   503   490
  Martinez Cantarin et al[@b26-cia-11-017]   128                     37         3                  140           65    5     0.4248   87.2   12.8   82.1   17.9   168   210
  Sanada et al[@b19-cia-11-017]              145                     286        157                181           227   77    0.6788   49.0   51.0   60.7   39.3   588   485
  Sun and Zhang[@b27-cia-11-017]             68                      34         3                  72            29    2     0.6376   81.0   19.1   84.0   16.0   105   103
  Cao et al[@b28-cia-11-017]                 19                      50         33                 28            48    17    0.6510   43.1   56.9   55.9   44.1   102   93
  Kimura et al[@b29-cia-11-017]              98                      72         8                  117           72    17    0.2200   75.3   24.7   74.3   25.7   178   206

**Note:** *P*~HWE~ represents the *P*-value of Hardy--Weinberg equilibrium test in the genotype distribution of controls.

###### 

Distribution of genotype and allele frequencies of the *DRD1* rs4532 locus

  Author                              Genotype distribution   *P*~HWE~   Allele frequency   Sample size                                                          
  ----------------------------------- ----------------------- ---------- ------------------ ------------- ----- ----- -------- ------ ------ ------ ------ ----- -----
  Sanada et al[@b19-cia-11-017]       6                       100        482                8             107   368   0.9447   9.5    90.5   12.7   87.3   588   483
  Beige et al[@b30-cia-11-017]        188                     253        52                 78            107   24    0.1601   63.8   36.2   62.9   37.1   493   209
  Cipolletta et al[@b31-cia-11-017]   33                      126        94                 12            51    36    0.3464   37.9   62.1   37.9   62.1   253   100
  Xu et al[@b20-cia-11-017]           211                     105        14                 147           44    4     0.7410   79.9   20.2   86.7   13.3   330   195
  Yuan et al[@b42-cia-11-017]         111                     68         8                  115           38    3     0.9460   77.5   22.5   85.9   14.1   187   156
  Sato et al[@b43-cia-11-017]         93                      35         3                  113           23    0     0.2814   84.4   15.6   91.5   8.5    131   136
  Orun et al[@b44-cia-11-017]         47                      36         18                 46            44    14    0.5051   64.4   35.6   65.4   34.6   101   104

**Note:** *P*~HWE~ represents the *P*-value of Hardy--Weinberg equilibrium test in the genotype distribution of controls.

###### 

Summarized ORs with 95% CIs for the association of *GRK4* and *DRD1* polymorphisms with hypertension

  Polymorphism        Genetic model             n   Statistical model   OR      95% CI         *P*~z~   *I*^2^ (%)   *P*~h~    *P*~e~
  ------------------- ------------------------- --- ------------------- ------- -------------- -------- ------------ --------- --------
  Rs1801058 (A486V)                                                                                                            
                      Allele contrast           7   Random              1.203   0.858--1.688   0.284    85.4         \<0.001   0.886
                      Homozygous codominant     7   Random              1.213   0.856--1.719   0.277    15.1         0.315     0.716
                      Heterozygous codominant   7   Random              1.223   0.760--1.969   0.407    85.6         \<0.001   0.848
                      Dominant                  7   Random              1.243   0.789--1.958   0.349    85.5         \<0.001   0.864
                      Recessive                 7   Random              1.155   0.815--1.639   0.418    28.5         0.211     0.687
  Rs2960306 (R65L)                                                                                                             
                      Allele contrast           6   Random              1.219   0.851--1.747   0.279    87.2         \<0.001   0.940
                      Homozygous codominant     6   Random              1.280   0.858--1.911   0.226    39.7         0.141     0.430
                      Heterozygous codominant   6   Random              1.278   0.768--2.126   0.344    87.3         \<0.001   0.882
                      Dominant                  6   Random              1.304   0.793--2.145   0.295    88.0         \<0.001   0.971
                      Recessive                 6   Random              1.144   0.858--1.525   0.360    8.3          0.363     0.504
  Rs1024323 (A142V)                                                                                                            
                      Allele contrast           9   Random              1.161   0.830--1.625   0.383    90.0         \<0.001   0.620
                      Homozygous codominant     9   Random              1.413   0.671--2.975   0.362    89.0         \<0.001   0.609
                      Heterozygous codominant   9   Random              1.120   0.796--1.577   0.515    77.7         \<0.001   0.630
                      Dominant                  9   Random              1.190   0.785--1.805   0.413    86.7         \<0.001   0.581
                      Recessive                 9   Random              1.257   0.745--2.123   0.391    82.3         \<0.001   0.593
  Rs4532                                                                                                                       
                      Allele contrast           7   Random              1.303   1.055--1.610   0.014    62.0         0.015     0.156
                      Homozygous codominant     7   Random              1.271   0.886--1.824   0.192    8.3          0.365     0.002
                      Heterozygous codominant   7   Random              1.287   0.976--1.696   0.073    44.8         0.093     0.947
                      Dominant                  7   Random              1.353   1.016--1.802   0.038    52.2         0.051     0.751
                      Recessive                 7   Random              1.282   1.039--1.582   0.021    0.0          0.445     0.289

**Notes:** n, the number of studies; *P*~z~, *P*-value for association test; *P*~h~, *P*-value for heterogeneity test; *P*~e~, *P*-value for publication bias test.

**Abbreviations:** ORs, odds ratios; CIs, confidence intervals.

###### 

Stratified analysis for the association of *GRK4* and *DRD1* polymorphisms with hypertension under dominant model

  Polymorphism        Subgroup type        Subgroup           n   OR      95% CI         *P*~z~   *I*^2^ (%)   *P*~h~
  ------------------- -------------------- ------------------ --- ------- -------------- -------- ------------ ---------
  Rs1801058 (A486V)                                                                                            
                      Ethnicity            Caucasians         2   1.133   0.800--1.604   0.481    0.0          0.650
                                           Africans           2   0.960   0.652--1.414   0.836    0.0          0.907
                                           East Asians        3   1.496   0.569--3.931   0.414    94.6         \<0.001
                      Source of controls   Hospital-based     3   1.162   0.786--1.718   0.451    0.0          0.782
                                           Population-based   4   1.302   0.663--2.557   0.443    92.6         \<0.001
  Rs2960306 (R65L)                                                                                             
                      Ethnicity            Caucasians         2   1.172   0.811--1.694   0.399    0.0          0.771
                                           Africans           2   1.158   0.780--1.719   0.466    0.0          0.354
                                           East Asians        2   1.462   0.435--4.911   0.539    97.5         \<0.001
                      Source of controls   Hospital-based     2   1.276   0.718--2.269   0.406    0.0          0.420
                                           Population-based   4   1.294   0.693--2.415   0.419    92.7         \<0.001
  Rs1024323 (A142V)                                                                                            
                      Ethnicity            Caucasians         2   1.826   1.215--2.745   0.004    0.0          0.636
                                           Africans           3   0.885   0.590--1.325   0.552    43.6         0.170
                                           East Asians        4   1.182   0.539--2.590   0.677    93.7         \<0.001
                      Source of controls   Hospital-based     4   1.546   1.092--2.190   0.014    0.0          0.600
                                           Population-based   5   1.000   0.556--1.800   0.999    92.5         \<0.001
  Rs4532                                                                                                       
                      Ethnicity            Caucasians         3   0.946   0.726--1.233   0.684    0.0          0.981
                                           East Asians        4   1.833   1.415--2.376   ,0.001   0.0          0.967
                      Source of controls   Hospital-based     4   1.337   0.913--1.960   0.136    65.4         0.034
                                           Population-based   3   1.391   0.801--2.416   0.241    48.0         0.146

**Notes:** n, the number of studies; *P*~z~, *P*-value for association test; *P*~h~, *P*-value for heterogeneity test.

**Abbreviations:** OR, odds ratio; CI, confidence interval.
